BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 25775144)

  • 1. Corticosteroid-sparing effect of tacrolimus in the initial treatment of dermatomyositis and polymyositis.
    Yokoyama Y; Furuta S; Ikeda K; Hirose K; Nakajima H
    Mod Rheumatol; 2015; 25(6):888-92. PubMed ID: 25775144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coadministration of tacrolimus with corticosteroid accelerates recovery in refractory patients with polymyositis/ dermatomyositis: a retrospective study.
    Shimojima Y; Ishii W; Matsuda M; Tazawa K; Ikeda S
    BMC Musculoskelet Disord; 2012 Nov; 13():228. PubMed ID: 23173570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab therapy in patients with refractory dermatomyositis or polymyositis: differential effects in a real-life population.
    Unger L; Kampf S; Lüthke K; Aringer M
    Rheumatology (Oxford); 2014 Sep; 53(9):1630-8. PubMed ID: 24706995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of tacrolimus in patients with refractory dermatomyositis/polymyositis: a systematic review.
    Ge Y; Zhou H; Shi J; Ye B; Peng Q; Lu X; Wang G
    Clin Rheumatol; 2015 Dec; 34(12):2097-103. PubMed ID: 26328518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis.
    Kurita T; Yasuda S; Oba K; Odani T; Kono M; Otomo K; Fujieda Y; Oku K; Bohgaki T; Amengual O; Horita T; Atsumi T
    Rheumatology (Oxford); 2015 Jan; 54(1):39-44. PubMed ID: 24764266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advantage of administering tacrolimus for improving prognosis of patients with polymyositis and dermatomyositis.
    Ueno KI; Shimojima Y; Kishida D; Sekijima Y; Ikeda SI
    Int J Rheum Dis; 2016 Dec; 19(12):1322-1330. PubMed ID: 27457756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tacrolimus on dermatomyositis and polymyositis: a prospective, open, non-randomized study of nine patients and a review of the literature.
    Matsubara S; Kondo K; Sugaya K; Miyamoto K
    Clin Rheumatol; 2012 Oct; 31(10):1493-8. PubMed ID: 22886003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.
    Nawata Y; Kurasawa K; Takabayashi K; Miike S; Watanabe N; Hiraguri M; Kita Y; Kawai M; Saito Y; Iwamoto I
    J Rheumatol; 1999 Jul; 26(7):1527-33. PubMed ID: 10405940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of adding tacrolimus to initial treatment of interstitial pneumonitis in polymyositis/dermatomyositis: a single-arm clinical trial.
    Takada K; Katada Y; Ito S; Hayashi T; Kishi J; Itoh K; Yamashita H; Hirakata M; Kawahata K; Kawakami A; Watanabe N; Atsumi T; Takasaki Y; Miyasaka N
    Rheumatology (Oxford); 2020 May; 59(5):1084-1093. PubMed ID: 31539061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: Interim Report of Postmarketing Surveillance in Japan.
    Kuwana M; Wakasugi N; Furuya T; Uno S; Suda T
    J Rheumatol; 2022 Jul; 49(7):707-718. PubMed ID: 35428708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of early treatment in polymyositis and dermatomyositis.
    Naji P; Shahram F; Nadji A; Davatchi F
    Neurol India; 2010; 58(1):58-61. PubMed ID: 20228465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis.
    Lundberg I; Kratz AK; Alexanderson H; Patarroyo M
    Arthritis Rheum; 2000 Feb; 43(2):336-48. PubMed ID: 10693873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of calcineurin inhibitors for the treatment of interstitial lung disease associated with polymyositis/dermatomyositis.
    Kurita T; Yasuda S; Amengual O; Atsumi T
    Lupus; 2015 Jan; 24(1):3-9. PubMed ID: 25297551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of tacrolimus in treatment of polymyositis associated with myasthenia gravis.
    Shimojima Y; Gono T; Yamamoto K; Hoshi K; Matsuda M; Yoshida K; Ikeda S
    Clin Rheumatol; 2004 Jun; 23(3):262-5. PubMed ID: 15168159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.
    Fujisawa T; Suda T; Nakamura Y; Enomoto N; Ide K; Toyoshima M; Uchiyama H; Tamura R; Ida M; Yagi T; Yasuda K; Genma H; Hayakawa H; Chida K; Nakamura H
    J Rheumatol; 2005 Jan; 32(1):58-64. PubMed ID: 15630726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, Controlled Trial of Tacrolimus and Prednisolone Monotherapy for Adults with
    Medjeral-Thomas NR; Lawrence C; Condon M; Sood B; Warwicker P; Brown H; Pattison J; Bhandari S; Barratt J; Turner N; Cook HT; Levy JB; Lightstone L; Pusey C; Galliford J; Cairns TD; Griffith M
    Clin J Am Soc Nephrol; 2020 Feb; 15(2):209-218. PubMed ID: 31953303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current therapy for polymyositis and dermatomyositis].
    Chérin P
    Rev Med Interne; 2008 Jun; 29 Spec No 2():9-14. PubMed ID: 18927983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis.
    Raouf J; Idborg H; Englund P; Alexanderson H; Dastmalchi M; Jakobsson PJ; Lundberg IE; Korotkova M
    Arthritis Res Ther; 2018 May; 20(1):83. PubMed ID: 29720222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort.
    Sharma N; Putman MS; Vij R; Strek ME; Dua A
    J Rheumatol; 2017 Nov; 44(11):1612-1618. PubMed ID: 28864644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trial.
    Fujisawa T; Hozumi H; Kamiya Y; Kaida Y; Akamatsu T; Kusagaya H; Satake Y; Mori K; Mikamo M; Matsuda H; Yokomura K; Koshimizu N; Toyoshima M; Imokawa S; Yasui H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
    Respirology; 2021 Apr; 26(4):370-377. PubMed ID: 33179395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.